WallStSmart

JPMorgan Chase & Co (JPM)vsTexas Capital Bancshares, Inc. (TCBIO)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

JPMorgan Chase & Co generates 14915% more annual revenue ($190.73B vs $1.27B). JPM leads profitability with a 34.6% profit margin vs 28.7%. TCBIO trades at a lower P/E of 4.6x. JPM earns a higher WallStSmart Score of 73/100 (B).

JPM

Strong Buy

73

out of 100

Grade: B

Growth: 7.3Profit: 8.0Value: 6.3Quality: 3.0
Piotroski: 4/9Altman Z: 0.55

TCBIO

Hold

48

out of 100

Grade: D+

Growth: 7.3Profit: 7.5Value: 6.7Quality: 6.3
Piotroski: 6/9Altman Z: 0.38

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

JPM6 strengths · Avg: 9.3/10
Market CapQuality
$895.04B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
34.6%10/10

Keeps 35 of every $100 in revenue as profit

Operating MarginProfitability
42.6%10/10

Strong operational efficiency at 42.6%

Free Cash FlowQuality
$33.16B10/10

Generating 33.2B in free cash flow

P/E RatioValuation
14.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

TCBIO5 strengths · Avg: 9.6/10
P/E RatioValuation
4.6x10/10

Attractively priced relative to earnings

Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
36.7%10/10

Strong operational efficiency at 36.7%

Profit MarginProfitability
28.7%9/10

Keeps 29 of every $100 in revenue as profit

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Areas to Watch

JPM2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.552/10

Distress zone — elevated risk

Debt/EquityHealth
3.321/10

Elevated debt levels

TCBIO1 concerns · Avg: 2.0/10
Altman Z-ScoreHealth
0.382/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : JPM

The strongest argument for JPM centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 34.6% and operating margin at 42.6%. Revenue growth of 10.2% demonstrates continued momentum.

Bull Case : TCBIO

The strongest argument for TCBIO centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 28.7% and operating margin at 36.7%.

Bear Case : JPM

The primary concerns for JPM are Altman Z-Score, Debt/Equity. Debt-to-equity of 3.32 is elevated, increasing financial risk.

Bear Case : TCBIO

The primary concerns for TCBIO are Altman Z-Score.

Key Dynamics to Monitor

JPM carries more volatility with a beta of 1.01 — expect wider price swings.

JPM is growing revenue faster at 10.2% — sustainability is the question.

JPM generates stronger free cash flow (33.2B), providing more financial flexibility.

Monitor BANKS - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

JPM scores higher overall (73/100 vs 48/100), backed by strong 34.6% margins and 10.2% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

JPMorgan Chase & Co

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

JPMorgan Chase & Co. is an American multinational investment bank and financial services holding company headquartered in New York City. JPMorgan Chase is incorporated in Delaware. As a Bulge Bracket bank, it is a major provider of various investment banking and financial services. It is one of America's Big Four banks, along with Bank of America, Citigroup, and Wells Fargo. JPMorgan Chase is considered to be a universal bank and a custodian bank. The J.P. Morgan brand is used by the investment banking, asset management, private banking, private wealth management, and treasury services divisions.

Visit Website →

Texas Capital Bancshares, Inc.

FINANCIAL SERVICES · BANKS - REGIONAL · USA

Texas Capital Bancshares, Inc. (TCBIO), headquartered in Dallas, Texas, is a leading regional bank that provides a comprehensive suite of financial services to both commercial and individual clients. The bank excels in delivering customized solutions, including business lending, treasury management, and personal banking, underpinned by a strong focus on client relationships and local market knowledge. With a strategic emphasis on prudent risk management and sustainable growth, TCBIO is optimally positioned to thrive in the competitive banking landscape while enhancing long-term shareholder value.

Want to dig deeper into these stocks?